Metoprololtartraat Sandoz (Metoprolol Tartrate)

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, preventing norepinephrine and epinephrine from binding. This reduces cyclic AMP production, leading to lower intracellular calcium, slower pacemaker activity, decreased contractility and reduced renin release, which together lower heart rate, myocardial oxygen demand and blood pressure.

The appropriate dose of Metoprololtartraat Sandoz is determined by the prescribing clinician based on the individual’s medical condition, response to therapy and any comorbidities. Dosage may be adjusted over time, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for metoprolol tartrate in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate each case individually and discuss alternatives when appropriate.

To request Metoprololtartraat Sandoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol tartrate is a cardio‑selective (β1‑specific) blocker, offering a favorable profile for patients with respiratory conditions compared with non‑selective agents. Compared with agents like atenolol, metoprolol has a shorter half‑life, allowing more flexible dosing, while still providing effective blood‑pressure and heart‑rate control.

Metoprololtartraat Sandoz tablets should be stored at ambient temperature, below 25 °C. Keep them in the original packaging, protect from moisture and light, and ensure the container is tightly closed to maintain product stability throughout its shelf life.

Metoprololtartraat Sandoz is taken orally, usually with or without food, as directed by a healthcare professional. The tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically advised.

Serious adverse events can include severe bradycardia, heart block, profound hypotension, bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and worsening heart failure. Patients should be monitored for these signs, especially when initiating therapy or adjusting the dose.

Metoprololtartraat Sandoz is contraindicated in individuals with overt second‑ or third‑degree heart block, cardiogenic shock, severe bradycardia (resting heart rate <50 bpm) without supervision, and in patients with severe asthma or uncontrolled bronchospastic disease. Clinicians must assess each patient’s medical history before prescribing.